Company Introduction

COMPANY

Kawai Pharmaceutical Co., Ltd.'s production line has a long history, strict management, and excellent quality assurance. Each product must pass multiple rigorous inspections, including machine inspection, manual inspection, and secondary machine inspection before leaving the factory.
Our product line is capable of producing class second and third drugs, quasi-drugs, health foods and cosmetics. It can also perform contracted manufacturing and various testing such as microbial inspections, pH measurement, viscosity measurement, and density measurement according to customer needs. The production line can handle long-term production contracts from multiple companies, with over 500 commissioned products, including popular stem cell supernatant series skincare products and NMN health foods.

Message from the President

President Kawai

In October 2023, Mr. Kawai Shin, CEO of Kawai Pharmaceutical Co., Ltd., was interviewed by the monthly business magazine "Kouwa Keiei Juku." During the interview, Mr. Kawai discussed the company's OEM philosophy—"fast, high-quality, fair pricing, and small lot production"—and its cutting-edge regenerative medicine technologies, which have garnered significant attention in the industry. The company's flagship brand, "VieMax (Ikihada)," has been a long-selling product for over a decade. Mr. Kawai, at 45 years old, leads the company with a strong commitment to research and development, focusing on high-quality cosmetic products. The name "VieMax" combines the French word "Vie" (life) and the English word "Max" (maximum), embodying the company's motto: "We want everyone to attain beauty and richness and live the 'best life' possible." This philosophy drives the young entrepreneur to continue striving for excellence. The "VieMax (Ikihada)" series includes skincare products, cosmetics, and health supplements designed to invigorate skin cells from the outside and promote the renewal and metabolism of body cells from the inside. By maintaining beautiful skin and promoting health, the company aims to deliver long-lasting wellness to its customers. Supporting a beautiful and healthy life is the ultimate goal of VieMax.

The company has always regarded product quality as the lifeblood of corporate development. From breeding silkworms to processing silk and subsequent essence production, every step undergoes multiple rigorous inspections and controls. The on-site management of the production line strictly adheres to operational rules to ensure the products can withstand market tests and earn the trust of consumers.

Corporate Goals

Kawai Pharmaceutical Co., Ltd. adheres to the "small but refined" development route, allocating all promotional and PR expenses to R&D. By relying on market reputation and consumer feedback, the company steadily expands its market share.

Through internationally renowned e-commerce platforms such as Amazon and Yahoo, VieMax Active Collagen Serum has successfully entered international markets. Besides being popular in mainland China, VieMax Active Collagen Serum has distribution channels in Hong Kong, Macau, Taiwan, Malaysia, Singapore, the United States, and Canada.
The company offers products such as Slim Enzyme Yeast, Slim Enzyme, Nucleic Acid, VieMax Active Silk Protein Masks, and the VieMax Active series to meet various care needs. These products are highly favored by both consumers and beauty salons at home and abroad.

Company Overview

Company Name Kawai Pharmaceutical Co., Ltd.
Head Office Location 〒157-0062 Room 503, Room 503, 6-19-9 Minami-Karasuyama, Setagaya-ku, Tokyo
Branch Office Location 〒160-0022 Room 206, Shiota Building, 6-27-10 Shinjuku, Shinjuku-ku, Tokyo
TEL/FAX TEL: 03-6279-0989 (Representative)
FAX: 03-6279-0987
Representative President Shun Kawai
Established 2023.02.09
Business Description
  • Sales of raw materials for cosmetics, medicines, and food
  • Planning and sales of containers and packaging materials
  • OEM production of skincare products, quasi-drugs, health supplements, and pharmaceuticals
Partner Banks Mitsubishi UFJ Bank

Company History

February 2023 Kawai Pharmaceutical Co., Ltd. Established.
June 2023 Sales & Manufacturing License for Cosmetics acquisition.
December 2023 Sales & Manufacturing License for Quasi-pharmaceutical products acquisition.
December 2024 Relocated the office to 6-27-10 Shinjuku, Shinjuku-ku, Tokyo.
January 2025 Pharmaceutical Wholesale License acquisition.

Transportation Guide

〒160-0022 Room 206, Shiota Building, 6-27-10 Shinjuku, Shinjuku-ku, Tokyo

◇ If arriving by train:
 The nearest station is Toei Oedo Line "Higashi-Shinjuku."
 It takes 5 minutes on foot from Higashi-Shinjuku Station.

◇ If arriving by car:
-->  There is a parking lot near office.